全球細胞重編程市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

細胞重編程市場預計將從 2025 年的 4.6554 億美元成長到 2034 年的 10.2116 億美元，2026 年至 2034 年的複合年成長率為 9.12%。

受再生醫學和幹細胞研究進展的推動，全球細胞重編程市場正經歷強勁成長。細胞重編程技術能夠將體細胞轉化為誘導多功能細胞，用於治療應用。組織工程和疾病模型領域研發的不斷深入也促進了市場擴張。此外，生物技術創新領域投資的持續成長進一步加速了市場發展。

主要成長要素包括對個人化醫療和再生醫學日益成長的需求。學術機構和生物技術公司正在投資研發旨在提高效率和安全性的新型再程式化技術。不斷擴大的臨床研究活動和政府資助也促進了這一成長。此外，基因編輯工具的進步也對細胞再程式化技術有了補充作用。

展望未來，再生醫學的商業化和細胞重編程技術的進步有望推動市場發展。新興經濟體對先進研究基礎設施的投資將創造新的機會。倫理考量和法規結構預計將影響科技的普及應用。隨著再生醫學的進步，全球細胞重編程市場預計將迎來顯著的長期成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球細胞重編程市場：依技術分類

• 市場分析、洞察與預測
• 利用仙台病毒進行重新編程
• mRNA再程式化
• 附加體重再程式化
• 其他

第5章 全球細胞重編程市場：依應用分類

• 市場分析、洞察與預測
• 調查
• 治療用途

第6章：全球細胞重編程市場：依最終用途分類

• 市場分析、洞察與預測
• 研究和學術機構
• 生物技術和製藥公司

第7章 全球細胞重編程市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Thermo Fisher Scientific Inc
  • Allele Biotechnology And Pharmaceuticals Inc
  • ALSTEM Inc
  • STEMCELL Technologies Inc
  • Merck KGaA
  • Bio-Techne Corporation
  • REPROCELL Inc
  • Lonza Group AG
  • FUJIFILM Corporation（Fujifilm Cellular Dynamics International Inc.）
  • Mogrify Limited

The Cell Reprogramming Market size is expected to reach USD 1021.16 Million in 2034 from USD 465.54 Million (2025) growing at a CAGR of 9.12% during 2026-2034.

The Global Cell Reprogramming Market is witnessing strong growth driven by advancements in regenerative medicine and stem cell research. Cell reprogramming technologies enable conversion of somatic cells into induced pluripotent stem cells for therapeutic applications. Increasing research in tissue engineering and disease modeling is supporting market expansion. Growing investment in biotechnology innovation is further accelerating development.

Key growth drivers include rising demand for personalized therapies and regenerative treatments. Academic institutions and biotech firms are investing in novel reprogramming techniques to enhance efficiency and safety. Expanding clinical research activities and supportive government funding are contributing to growth. Additionally, advancements in gene editing tools are complementing cell reprogramming technologies.

Looking ahead, the market is expected to benefit from commercialization of regenerative therapies and improved reprogramming methods. Emerging economies investing in advanced research infrastructure will create new opportunities. Ethical considerations and regulatory frameworks will influence adoption. As regenerative medicine progresses, the Global Cell Reprogramming Market is poised for substantial long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

• Sendai Virus-based Reprogramming
• mRNA Reprogramming
• Episomal Reprogramming
• Others

By Application

• Research
• Therapeutic

By End Use

• Research & Academic Institutes
• Biotechnology & Pharmaceutical Companies

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, Allele Biotechnology and Pharmaceuticals Inc, ALSTEM Inc, STEMCELL Technologies Inc, Merck KGaA, BioTechne Corporation, REPROCELL Inc, Lonza Group AG, FUJIFILM Corporation Fujifilm Cellular Dynamics International Inc, Mogrify Limited
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CELL REPROGRAMMING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. Sendai Virus-based Reprogramming Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. mRNA Reprogramming Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Episomal Reprogramming Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CELL REPROGRAMMING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Therapeutic Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CELL REPROGRAMMING MARKET: BY END USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Use
• 6.2. Research & Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Biotechnology & Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CELL REPROGRAMMING MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Technology
  • 7.2.2 By Application
  • 7.2.3 By End Use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Technology
  • 7.3.2 By Application
  • 7.3.3 By End Use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Technology
  • 7.4.2 By Application
  • 7.4.3 By End Use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Technology
  • 7.5.2 By Application
  • 7.5.3 By End Use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Technology
  • 7.6.2 By Application
  • 7.6.3 By End Use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CELL REPROGRAMMING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Thermo Fisher Scientific Inc
  • 9.2.2 Allele Biotechnology And Pharmaceuticals Inc
  • 9.2.3 ALSTEM Inc
  • 9.2.4 STEMCELL Technologies Inc
  • 9.2.5 Merck KGaA
  • 9.2.6 Bio-Techne Corporation
  • 9.2.7 REPROCELL Inc
  • 9.2.8 Lonza Group AG
  • 9.2.9 FUJIFILM Corporation (Fujifilm Cellular Dynamics International Inc.)
  • 9.2.10 Mogrify Limited